Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Drug-metabolizing enzyme genotypes and aggressive behavior treatment response in hospitalized pediatric psychiatric patients.

Journal of child and adolescent psychopharmacology - 1 Aug 2009

Prows Cynthia A, Nick Todd G, Saldaña Shannon N, Pathak Sanjeev, Liu Chunyan, Zhang Kejian, Daniels Zachary S, Vinks Alexander A, Glauser Tracy A

Abstract excerpt

OBJECTIVE: The aim of this study was to examine the association between the CYP2D6 and CYP2C19 genotype-predicted combined phenotypes and short-term measures of psychotropic efficacy and toxicity. METHODS: A rater-blinded, retrospective genotype association design examined a cohort of hospitalized pediatric psychiatric patients genotyped for CYP2D6 and CYP2C19 as part of clinical care. These combined genotypes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aggression
Share to Aryl Hydrocarbon Hydroxylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Child Behavior Disorders

Share to Cytochrome P-450 CYP2C19

Share to Cytochrome P-450 CYP2D6

Share to Hospitalization

Share to Mental Disorders

Share to Psychotropic Drugs

Source

Open in PubMed Open full text

Identifiers

PMID: 19702490
DOI: 10.1089/cap.2008.0103
PMCID: PMC2861955

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Drug-metabolizing enzyme genotypes and aggressive behavior treatment response in hospitalized pediatric psychiatric patients.PMID 19702490Read ↗

CYP450 2D6 and 2C19 genotypes in ADHD: not related with treatment resistance but with over-representation of 2C19 ultra-metabolizers.Semantic proximity Read ↗

Pharmacogenetics of Cytochrome P450 Enzymes in American Indian and Caucasian Children Admitted to a Psychiatric Hospital.Semantic proximity Read ↗

Genetic Polymorphisms <em>CYP3A4*22</em>, <em>CYP3A5*3</em>, and CYP2D6 Predicted Phenotype are not Associated with Antipsychotic Treatment Outcomes in Neurotypical Prepubertal Boys with Conduct DisordersSemantic proximity Read ↗

Dopamine Transporter and CYP2D6 Gene Relationships with Attention-Deficit/Hyperactivity Disorder Treatment Response in the Methylphenidate and Atomoxetine Crossover Study.Semantic proximity Read ↗

Impact of Cytochrome P450 Genetic Variation on Patient-Reported Symptom Improvement and Side Effects Among Children and Adolescents Treated with Fluoxetine.Semantic proximity Read ↗

Pharmacogenetics to Predict Adverse Events Associated With Antidepressants.Semantic proximity Read ↗

Identifying genomic and developmental causes of adverse drug reactions in children.Semantic proximity Read ↗

Pharmacogenetic Testing for Analgesic Adverse Effects: Pediatric Case Series.Semantic proximity Read ↗

CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD.Semantic proximity Read ↗

Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genotyping and therapeutic drug monitoring to dance together.Semantic proximity Read ↗

Evidence for Pharmacogenomic Effects on Risperidone Outcomes in Pediatrics.Semantic proximity Read ↗

Single dose, CYP2D6 genotype-stratified pharmacokinetic study of atomoxetine in children with ADHD.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.